Alpern Paul L 4

What Happened Paul L. Alpern, Vice President and General Counsel of Arteris, exercised stock options and sold shares on June 1, 2026. He acquired 4,000 shares at $0.56 ($2,240) and 2,500 shares at $9.28 ($23,200) through option exercises (total cost reported $25,440). On the same day he sold 11,504 shares at a weighted average price of $35.98 for $413,969 and 998 shares at a weighted average price of $36.39 for $36,317 (total sales proceeds ≈ $450,286). The Form 4 also reports two derivative disposals of 4,000 and 2,500 shares at $0.00 (reported as part of the option exercise mechanics).

Key Details

• Transaction date: 2026-06-01; Form 4 filed 2026-06-03 (appears timely).
• Option exercises acquired: 4,000 @ $0.56 ($2,240) and 2,500 @ $9.28 ($23,200).
• Open-market sales: 11,504 @ weighted avg $35.98 (range $35.27–$36.26) and 998 @ weighted avg $36.39 (range $36.28–$36.56); total ≈ $450,286. (Footnotes F2/F3: weighted-average price ranges; issuer/staff can request per-trade breakdown.)
• Zero-dollar derivative disposals: 4,000 and 2,500 shares reported at $0.00 (shown as derivative dispositions in the filing).
• Shares owned after the transaction: not specified in the provided Form 4 excerpt.
• Notable footnotes: trades were made pursuant to a 10b5-1 trading plan adopted Feb 23, 2026 (F1). Footnotes also reference incentive stock options and non-qualified stock options with stated vesting schedules (F4, F5).

Context The filing shows an option exercise paired with immediate open-market sales, a common pattern when insiders exercise and sell shares to cover exercise costs or taxes (the zero-dollar derivative disposals likely reflect those mechanics). Sales were executed under a pre-established 10b5-1 plan, which is intended to reduce the appearance of trading on insider information. This activity is a combination of option exercise (acquisition) and routine selling — not an explicit endorsement or negative signal about the company's prospects.